C4 Therapeutics (CCCC) Common Equity (2019 - 2026)
C4 Therapeutics' Common Equity came in at $247.27 million for Q2 2026, up 42.1% from $174.06 million a year earlier and up 5.6% from the prior quarter.
C4 Therapeutics (CCCC) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, C4 Therapeutics' Common Equity was $256.59 million, up 18.8% from FY2024.
- Common Equity carries a five-year compound annual growth rate of -1.8% (FY2020 to FY2025).
- Going back by year, Common Equity was $215.99 million in FY2024 (-12.2%), $246.11 million in FY2023 (-14.9%), $289.23 million in FY2022 (-25.8%) and $389.61 million in FY2021 (+38.8%).
- The five-year range for quarterly Common Equity is $154.41 million (Q3 2025) to $398.78 million (Q3 2021).
- Year-over-year, Common Equity has increased for three consecutive quarters, with an average decline of 1.2% over the last eight quarters.
- The fastest year-over-year change in Common Equity over five years came in Q2 2026 (growth of 42.1%), and the weakest in Q3 2025 (a decline of 36.4%).
- Business Quant data shows CCCC's Common Equity at $234.25 million (Q1 2026), $256.59 million (Q4 2025) and $154.41 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | C4 Therapeutics | 383.47 Mn | -546.29 Mn | - | 247.27 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 247.27 Mn |
| Mar 31, 2026 | 234.25 Mn |
| Dec 31, 2025 | 256.59 Mn |
| Sep 30, 2025 | 154.41 Mn |
| Jun 30, 2025 | 174.06 Mn |
| Mar 31, 2025 | 195.14 Mn |
| Dec 31, 2024 | 215.99 Mn |
| Sep 30, 2024 | 242.66 Mn |
| Jun 30, 2024 | 247.06 Mn |
| Mar 31, 2024 | 258.28 Mn |
| Dec 31, 2023 | 246.11 Mn |
| Sep 30, 2023 | 216.02 Mn |
| Jun 30, 2023 | 233.71 Mn |
| Mar 31, 2023 | 262.47 Mn |
| Dec 31, 2022 | 289.23 Mn |
| Sep 30, 2022 | 318.18 Mn |
| Jun 30, 2022 | 344.59 Mn |
| Mar 31, 2022 | 364.53 Mn |
| Dec 31, 2021 | 389.61 Mn |
| Sep 30, 2021 | 398.78 Mn |
C4 Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CCCC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CCCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CCCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();